Cardiac bioimplant market report
Biomems market technology 2013 Report by Yole Developpement
TCT 2011 | San Francisco, CA | November 10, 2011 Two-Year Outcomes of Transcatheter Aortic Valve Replacement (TAVR) in Inoperable Patients With Severe.
London Bridge Hospital Orientation January 2011 COMPANY CONFIDENTIAL NOT FOR DISTRIBUTION.
Icd lead extraction ba nov 2012 final
Ecg nesto
European Market for Cardiac Surgery Devices 2014
The DEFLECT III Trial: A Prospective Randomized Evaluation of the TriGuard Embolic DEFLECTion Device during Transcatheter Aortic Valve Replacement Alexandra.
Potential Utility of rNAPC2 in ACS: Phase 2 Heparin Replacement Trial Evaluating RNAPc2 In Acute Coronary Syndromes Potential Utility of rNAPC2 in ACS:
DANPACE: The Danish multicenter randomised trial on AAIR versus DDDR pacing in sick sinus syndrome Jens Cosedis Nielsen, Aarhus University Hospital on.
Optimal Method and Outcomes of Catheter Ablation of Persistent AF: The STAR AF 2 Trial Atul Verma, Jiang Chen-yang, Tim Betts, John Radcliffe, Jian Chen,
ICD terapija kod dece i adolescenata Goran Milašinović PMC, KCS.
